15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design.

Seoul National University
Targeting QPCTL: An Emerging Therapeutic Opportunity.

Tongji University Cancer Center
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.

Johann Wolfgang Goethe University
X-ray Structure-Guided Discovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That Shows Activity in a Parkinson's Disease Mouse Model.

Sichuan University
Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents.

Seoul National University
2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRPα Checkpoint.

Ewha Womans University
Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design.

Seoul National University
Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design.

Seoul National University
ANTAGONIST OF ADENOSINE RECEPTORS

AdoRx Therapeutics
SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT

Merck Sharp & Dohme
Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors

Lilac Therapeutics
BENZOPYRAZOLE INHIBITORS OF SARM1

Disarm Therapeutics
Conduritol aziridine derivatives and uses thereof

University of Saskatchewan
Functional selectivity of melanocortin 4 receptor peptide and nonpeptide agonists: evidence for ligand-specific conformational states.

Neurocrine Biosciences